首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1820101

2025-2033 年宏基因體學市場報告（按產品、技術、應用和地區）

Metagenomics Market Report by Product, Technology, Application, and Region 2025-2033

出版日期: 2025年09月01日 | 出版商:

IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024 年全球宏基因體學市場規模達 6.191 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 14.541 億美元，2025-2033 年期間的成長率 (CAGR) 為 9.45%。

宏基因體學是指對自然環境中微生物基因組的研究。它透過克隆基因組來研究其生態學、進化和多樣性，從而避免了對單一物種進行分離和實驗室培養的需要。宏基因體學利用定序和生物資訊技術來獲取科學見解，並作為分子工具，用於分析從水、土壤和人類排泄物等環境樣本中獲取的脫氧核糖核酸 (DNA)。這些樣本會透過序列讀取、基因預測、分箱和功能註釋進行進一步處理。這些見解可用於診斷傳染病、環境修復、腸道微生物表徵和生物燃料的開發。

宏基因體學市場趨勢：

在全球範圍內，腹瀉、流感、B型肝炎和愛滋病毒/愛滋病等病毒性感染的日益普及是推動市場成長的關鍵因素之一。此外，對及時診斷腦膜炎和腦炎等神經感染性疾病的有效解決方案的需求不斷成長，也為市場成長提供了動力。同時，宏基因體學也有助於識別可能導致食源性疾病爆發的細菌病原體，這進一步促進了市場的成長。與傳統技術相比，宏基因組學所需的預測序步驟更少，提高了長序列讀取的真實性，並提供了更高的讀取準確率。此外，各種技術進步，例如下一代定序服務的開發，也是其他促進成長的因素。這些解決方案與資料分析軟體整合，可加快資料分析和樣本處理速度。其他因素，包括生命科學領域的廣泛研究和開發 (R&D) 活動，以及擴大利用宏基因組學來製造永續農產品，預計將推動市場成長。

本報告回答的關鍵問題：

全球宏基因體學市場迄今表現如何？未來幾年將如何表現？
COVID-19 對全球宏基因體學市場有何影響？
主要的區域市場有哪些？
根據產品，市場是如何分類的？
基於技術的市場區隔是怎樣的？
根據應用，市場是如何分類的？
該產業的價值鏈分為哪些階段？
該行業的主要促進因素和挑戰是什麼？
全球宏基因體學市場的結構是怎麼樣的？主要參與者是誰？
產業競爭程度如何？

市場結構
關鍵參與者
關鍵參與者簡介
- Agilent Technologies Inc.
- Enterome
- Eurofins Scientific
- F. Hoffmann-La Roche AG (Roche Holding AG)
- Illumina Inc
- Novogene Co. Ltd.
- Oxford Nanopore Technologies Limited
- Pacific Biosciences of California Inc.
- PerkinElmer Inc.
- QIAGEN NV
- Swift Biosciences Inc. (Danaher Corporation)
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112025A4344

The global metagenomics market size reached USD 619.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,454.1 Million by 2033, exhibiting a growth rate (CAGR) of 9.45% during 2025-2033.

Metagenomics refers to the study of microbial genomes in the natural environment. It involves cloning of the genome to study the ecology, evolution and diversity, thereby bypassing the need for isolation and laboratory cultivation of individual species. Metagenomics uses sequencing and bioinformatics technologies to obtain scientific insights and is utilized as a molecular tool for analyzing the deoxyribonucleic acid (DNA) acquired from the environmental samples through water, soil and human waste. The samples are further processed through sequence reading, gene prediction, binning and functional annotation. The insights are used to diagnose infectious diseases, environmental remediation, gut microbe characterization and the development of biofuels.

Metagenomics Market Trends:

The increasing prevalence of virus-induced infections, such as diarrhea, influenza, hepatitis B, and HIV/AIDS, across the globe, is among the key factors driving the market growth. Moreover, the rising demand for effective solutions for the timely diagnosis of neuroinfectious diseases, such as meningitis and encephalitis, is providing a thrust to the market growth. In line with this, metagenomics also aids in identifying bacterial pathogens that can lead to foodborne disease outbreaks, which is further contributing to the growth of the market. In comparison to the traditionally used technologies, metagenomics requires a lesser number of pre-sequencing steps, enhances the authenticity of long readings and offers high read accuracy. Additionally, various technological advancements, such as the development of next-generation sequencing services, are acting as other growth-inducing factors. These solutions are integrated with data analysis software for faster data analysis and sample processing. Other factors, including extensive research and development (R&D) activities in the field of life sciences, along with the increasing utilization of metagenomics for manufacturing sustainable agricultural products, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Product:

Instruments and Software
Consumables

Breakup by Technology:

Sequencing
Bioinformatics

Breakup by Application:

Infectious Disease Diagnosis
Environmental Remediation
Gut Microbe Characterization
Biotechnology
Biofuel
Agriculture

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc, Enterome, Eurofins Scientific, F. Hoffmann-La Roche AG (Roche Holding AG), Illumina Inc, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. (Danaher Corporation) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

How has the global metagenomics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global metagenomics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global metagenomics market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Metagenomics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Instruments and Software
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Consumables
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Technology

7.1 Sequencing
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Bioinformatics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Application

8.1 Infectious Disease Diagnosis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Environmental Remediation
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Gut Microbe Characterization
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Biotechnology
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Biofuel
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Agriculture
- 8.6.1 Market Trends
- 8.6.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Agilent Technologies Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Enterome
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Eurofins Scientific
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 F. Hoffmann-La Roche AG (Roche Holding AG)
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 SWOT Analysis
- 14.3.5 Illumina Inc
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Novogene Co. Ltd.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Oxford Nanopore Technologies Limited
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 SWOT Analysis
- 14.3.8 Pacific Biosciences of California Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 PerkinElmer Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 QIAGEN N.V.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Swift Biosciences Inc. (Danaher Corporation)
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
- 14.3.12 Thermo Fisher Scientific Inc.
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Metagenomics Market: Major Drivers and Challenges
Figure 2: Global: Metagenomics Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: Global: Metagenomics Market: Breakup by Product (in %), 2024
Figure 5: Global: Metagenomics Market: Breakup by Technology (in %), 2024
Figure 6: Global: Metagenomics Market: Breakup by Application (in %), 2024
Figure 7: Global: Metagenomics Market: Breakup by Region (in %), 2024
Figure 8: Global: Metagenomics (Instruments and Software) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Metagenomics (Instruments and Software) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Metagenomics (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Metagenomics (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Metagenomics (Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Metagenomics (Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Metagenomics (Bioinformatics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Metagenomics (Bioinformatics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Metagenomics (Infectious Disease Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Metagenomics (Infectious Disease Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Metagenomics (Environmental Remediation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Metagenomics (Environmental Remediation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Metagenomics (Gut Microbe Characterization) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Metagenomics (Gut Microbe Characterization) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Metagenomics (Biotechnology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Metagenomics (Biotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Metagenomics (Biofuel) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Metagenomics (Biofuel) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Metagenomics (Agriculture) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Metagenomics (Agriculture) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: North America: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: North America: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: United States: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: United States: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Canada: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Canada: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Asia-Pacific: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Asia-Pacific: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: China: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: China: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Japan: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Japan: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: India: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: India: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: South Korea: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: South Korea: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Australia: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Australia: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Indonesia: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Indonesia: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Others: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Others: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Europe: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Europe: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Germany: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Germany: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: France: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: France: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: United Kingdom: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: United Kingdom: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Italy: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Italy: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Spain: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Spain: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Russia: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Russia: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Others: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Others: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Latin America: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Latin America: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Brazil: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Brazil: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Mexico: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Mexico: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Others: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Others: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Middle East and Africa: Metagenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Middle East and Africa: Metagenomics Market: Breakup by Country (in %), 2024
Figure 76: Middle East and Africa: Metagenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Global: Metagenomics Industry: SWOT Analysis
Figure 78: Global: Metagenomics Industry: Value Chain Analysis
Figure 79: Global: Metagenomics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Metagenomics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Metagenomics Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Metagenomics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 4: Global: Metagenomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Metagenomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Metagenomics Market: Competitive Structure
Table 7: Global: Metagenomics Market: Key Players

02-2729-4219

+886-2-2729-4219